These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7288634)

  • 1. Bromobenzene epoxidation leading to binding on macromolecular protein sites.
    Lau SS; Zannoni VG
    J Pharmacol Exp Ther; 1981 Nov; 219(2):563-72. PubMed ID: 7288634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsomal metabolism and covalent binding of [3H/14C]-bromobenzene. Evidence for quinones as reactive metabolites.
    Narasimhan N; Weller PE; Buben JA; Wiley RA; Hanzlik RP
    Xenobiotica; 1988 May; 18(5):491-9. PubMed ID: 3400271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiple reactive metabolites derived from bromobenzene.
    Lau SS; Monks TJ; Gillette JR
    Drug Metab Dispos; 1984; 12(3):291-6. PubMed ID: 6145555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic bromobenzene epoxidation and binding: prevention by ascorbyl palmitate.
    Zannoni VG; Marker EK; Lau SS
    Drug Nutr Interact; 1982; 1(3):193-204. PubMed ID: 6926828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of human and mouse liver microsomal metabolism of bromobenzene and chlorobenzene to 2- and 4-halophenols.
    Kerger BD; Roberts SM; James RC
    Drug Metab Dispos; 1988; 16(5):672-7. PubMed ID: 2906588
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Covalent interaction of metabolites of the carcinogen trichloroethylene in rat hepatic microsomes.
    Van Duuren BL; Banerjee S
    Cancer Res; 1976 Jul; 36(7 PT 1):2419-22. PubMed ID: 1277148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of a rat liver microsomal esterase as a target protein for bromobenzene metabolites.
    Rombach EM; Hanzlik RP
    Chem Res Toxicol; 1998 Mar; 11(3):178-84. PubMed ID: 9544615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion of reactive metabolites out of hepatocytes: studies with bromobenzene.
    Monks TJ; Lau SS; Gillette JR
    J Pharmacol Exp Ther; 1984 Feb; 228(2):393-9. PubMed ID: 6694117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of chemical and enzymic probes on microsomal covalent binding of bromobenzene and derivatives. Evidence for quinones as reactive metabolites.
    Buben JA; Narasimhan N; Hanzlik RP
    Xenobiotica; 1988 May; 18(5):501-10. PubMed ID: 3400272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of phenolic metabolites in the irreversible protein-binding of 14C-bromobenzene catalysed by rat liver microsomes.
    Hesse S; Wolff T; Mezger M
    Arch Toxicol Suppl; 1980; 4():358-62. PubMed ID: 6933937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in cytochrome P450-mediated biotransformation of 1,2-dichlorobenzene by rat and man: implications for human risk assessment.
    Hissink AM; Oudshoorn MJ; Van Ommen B; Haenen GR; Van Bladeren PJ
    Chem Res Toxicol; 1996 Dec; 9(8):1249-56. PubMed ID: 8951226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose-dependent metabolic excretion of bromobenzene and its possible relationship to hepatotoxicity in rats.
    Chakrabarti S; Brodeur J
    J Toxicol Environ Health; 1984; 14(2-3):379-91. PubMed ID: 6502740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic microsomal epoxidation of bromobenzene to phenols and its toxicological implication.
    Lau SS; Zannoni VG
    Toxicol Appl Pharmacol; 1979 Sep; 50(2):309-18. PubMed ID: 505459
    [No Abstract]   [Full Text] [Related]  

  • 14. The mechanism of formation of o-bromophenol from bromobenzene.
    Monks TJ; Lau SS; Pohl LR; Gillette JR
    Drug Metab Dispos; 1984; 12(2):193-8. PubMed ID: 6144485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation and detoxification of bromobenzene in extrahepatic tissues.
    Monks TJ; Lau SS
    Life Sci; 1984 Jul; 35(5):561-8. PubMed ID: 6748863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The covalent binding of bromobenzene with nucleic acids.
    Colacci A; Arfellini G; Mazzullo M; Prodi G; Grilli S
    Toxicol Pathol; 1985; 13(4):276-82. PubMed ID: 2422722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of epoxide- and quinone-derived bromobenzene adducts to protein sulfur nucleophiles.
    Slaughter DE; Hanzlik RP
    Chem Res Toxicol; 1991; 4(3):349-59. PubMed ID: 1912319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereochemical aspects of vinylcyclohexene bioactivation in rodent hepatic microsomes and purified human cytochrome P450 enzyme systems.
    Fontaine SM; Mash EA; Hoyer PB; Sipes IG
    Drug Metab Dispos; 2001 Feb; 29(2):179-84. PubMed ID: 11159809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemical models for toxic metabolites of bromobenzene derivatives. Relative toxicity toward isolated hepatocytes.
    Gottschall DW; Harder RR; Wiley RA; Hanzlik RP
    Toxicology; 1984 Jun; 31(3-4):251-9. PubMed ID: 6740700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of verlukast metabolites arising from an epoxide intermediate produced with hepatic microsomes from beta-naphthoflavone-treated rodents (P-4501A1).
    Nicoll-Griffith DA; Chauret N; Yergey JA; Trimble LA; Favreau L; Zamboni R; Grossman SJ; Drey J; Herold E
    Drug Metab Dispos; 1993; 21(5):861-7. PubMed ID: 7902249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.